Fig. 12.
HPMA copolymer–9-aminocamptothecin conjugate. (A) Structure and scheme of release of unmodified 9-AC from HPMA copolymer–9-AC conjugates by a two-step process – rate controlling aromatic azo bond cleavage, followed by fast 1,6-elimination [51]; (B) survival curves of mice bearing human colon carcinoma xenografts treated by 9-AC and P-9-AC at a dose of 3 mg/kg of 9-AC or 9-AC equivalent [138].
